VAISHALIPharmaceuticals
Vaishali Pharma Ltd — Cash Flow Statement
₹4.88
-9.60%
Vaishali Pharma Ltd Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Changes In Cash | 0.59 Cr | -0.37 Cr | 0.89 Cr | 0.09 Cr |
| Financing Cash Flow | -1.42 Cr | -1.73 Cr | 0.42 Cr | -1.81 Cr |
| Interest Paid Cff | -1.74 Cr | -1.89 Cr | -2.44 Cr | -2.62 Cr |
| Net Common Stock Issuance | 1.57 Cr | 5.03 Cr | -0.10 Cr | 0.00 |
| Common Stock Issuance | 1.57 Cr | 5.03 Cr | — | — |
| Net Issuance Payments Of Debt | -1.05 Cr | -4.50 Cr | 3.19 Cr | 0.94 Cr |
| Net Short Term Debt Issuance | 0.28 Cr | -6.76 Cr | 5.07 Cr | -13134.00 |
| Net Long Term Debt Issuance | -1.33 Cr | 2.25 Cr | -1.88 Cr | 0.94 Cr |
| Investing Cash Flow | 1.20 Cr | 0.28 Cr | -0.85 Cr | -0.11 Cr |
| Interest Received Cfi | 1.31 Cr | 0.58 Cr | 0.02 Cr | 0.02 Cr |
| Dividends Received Cfi | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 |
| Net PPE Purchase And Sale | -0.11 Cr | -0.30 Cr | -0.86 Cr | -0.13 Cr |
| Purchase Of PPE | -0.11 Cr | -0.30 Cr | -0.86 Cr | -0.13 Cr |
| Operating Cash Flow | 0.81 Cr | 1.08 Cr | 1.32 Cr | 2.01 Cr |
| Taxes Refund Paid | -2.28 Cr | -1.56 Cr | -0.83 Cr | -0.06 Cr |
| Change In Working Capital | -3.70 Cr | -7.36 Cr | -5.20 Cr | -2.78 Cr |
| Change In Other Current Assets | -0.19 Cr | 1.52 Cr | -1.09 Cr | 0.54 Cr |
| Change In Payable | -5.85 Cr | -10.29 Cr | -12.16 Cr | 17.05 Cr |
| Change In Inventory | 2.67 Cr | -2.42 Cr | -0.04 Cr | 0.29 Cr |
| Change In Receivables | 0.06 Cr | 4.90 Cr | 8.23 Cr | -21.52 Cr |
| Other Non Cash Items | 0.25 Cr | 0.66 Cr | 1.16 Cr | 1.20 Cr |
| Depreciation And Amortization | 0.51 Cr | 0.50 Cr | 0.46 Cr | 0.43 Cr |
| Amortization Cash Flow | 0.12 Cr | 0.10 Cr | — | — |
| Depreciation | 0.38 Cr | 0.40 Cr | 0.46 Cr | 0.43 Cr |
| Net Income From Continuing Operations | 0.93 Cr | 8.85 Cr | 5.73 Cr | 1.40 Cr |
| Free Cash Flow | 0.70 Cr | 0.78 Cr | 0.45 Cr | 1.89 Cr |
| Issuance Of Capital Stock | 1.57 Cr | 5.03 Cr | — | — |
| Capital Expenditure | -0.11 Cr | -0.30 Cr | -0.86 Cr | -0.13 Cr |
| End Cash Position | 1.58 Cr | 0.98 Cr | 1.36 Cr | 0.47 Cr |
| Beginning Cash Position | 0.98 Cr | 1.36 Cr | 0.47 Cr | 0.38 Cr |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | -2000.00 | — |
| Net Other Financing Charges | — | 1000.00 | 1000.00 | — |
| Repurchase Of Capital Stock | — | — | -0.10 Cr | 0.00 |
| Common Stock Payments | — | — | -0.10 Cr | 0.00 |
| Purchase Of Investment | — | — | 0.00 | 0.00 |
| Gain Loss On Investment Securities | — | — | -75.00 | — |
| Change In Other Current Liabilities | — | — | — | 0.46 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vaishali Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.